Company Information
USD
5.388
- (3.8%)
NASDAQ:PRE, PRENETICS GLOBAL LTD
Industry: Diagnostics & Research
End of Day: 9 May 2025 GMT-4
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.
Address
Unit 701-706, K11 Atelier King’s Road
728 King’s Road, Quarry Bay
Website
Classification
Sector
Healthcare
Industry Group
Medical Diagnostics & Research
Industry
Diagnostics & Research
Key Executives
Ms. Wing Kwan Winnie Chiu
Director
Mr. Yin Pan Cheng
Director
Mr. Danny Sheng Wu Yeung
CEO/Chairman of the Board/Co-Founder/Director
Dr. Zhanfeng Cui
Director
Mr. Ian Ying Woo
Director
Mr. Chi Hung Lawrence Tzang
Chief Scientific Officer/Co-Founder
Mr. Hoi Chun Stephen Lo
CFO
Dr. Shih-Chang Frank Ong
Chief Medical Officer
Dr. Senthil Sundaram
Other Executive Officer
Dr. Yung Ho Peter Wong
Chief Technology Officer
Ownership
Institution Holdings
Prudential Corp PLC
684,822 (5.698%)
Eastspring Investments (Singapore) Ltd
684,822 (5.611%)
Aspex Management (HK) Ltd
346,150 (2.880%)
Nomura Holdings Inc
193,963 (1.614%)
Fidelity Management & Research Company LLC
2,985 (0.025%)
Yu Fan
25,000 (0.014%)
Aspire Private Capital, LLC
114 (0.001%)
Bank of America Corp
111 (0.001%)
Wolverine Asset Management LLC
1 (0.000%)
Make Smart Investment Choices